-
-
-
-
-
-
-
Hims & Hers launches generic semaglutide in Canada at $149 monthly
-
-
-
-
-
-
-
Hims and Hers (HIMS) PT Raised to $25 at TD Cowen
-
-
-
-
-
-
-
Hims & Hers earnings preview: BofA says company lost GLP-1 share in 1Q
-
-
-
-
-
-
-
Hims and Hers (HIMS) PT Raised to $32 at BofA Securities
-
-
-
-
-
-
-
Hims and Hers (HIMS) PT Raised to $25 at BofA Securities
-
-
-
-
-
-
-
HIMS partners with Novo Nordisk to offer FDA-approved GLP-1 medications
-
-
-
-
-
-
-
Citi Upgrades Hims and Hers (HIMS) to Neutral
-
414,233 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

